Omnipod Lawsuit Lawyers

The defective medical devices lawyers at The Buckfire Law firm represent clients who suffered harm from an Omnipod© insulin pump.

In March 2026, Insulet Corporation announced a voluntary medical device correction affecting certain Omnipod 5 pods distributed in the United States. The Insulet Omnipod recall has led to lawsuits concerning the Omnipod 5 insulin pump, as affected users seek legal recourse for injuries related to the device. The issue stems from a manufacturing defect that can cause insulin to leak inside the pod instead of being delivered properly into the patient’s body. This page explains the recall, associated health risks, and legal options for those injured by defective pods.

• What Injuries are Linked to Defective Omnipod Pods?
• Which Omnipod 5 Pods are Affected?
• What Should Current Omnipod 5 Users Do?
• Do I Qualify to File an Omnipod Lawsuit?
• Contact an Omnipod Lawsuit Attorney

Omnipod 5 Recall and Lawsuit Overview

Insulet Corporation initiated this correction after identifying a small tear in the internal tubing of certain Omnipod 5 pods. When this defect occurs, less insulin reaches the patient, potentially causing high blood glucose levels that can progress to diabetic ketoacidosis—a life-threatening condition that requires prompt medical treatment.

According to FDA and company reports, at least 18 serious adverse events connected to this defect have been documented, including hospitalization of diabetic ketoacidosis cases. No deaths have been reported as of the latest update.

Key points about this recall:

• Date: March 2026
• Product: Certain Omnipod 5 automated insulin delivery pods (U.S. distribution)
• Defect: Internal tubing tear causing insulin leakage and under-delivery
• Injuries: 18 serious adverse events, including DKA and hospitalizations
• Legal implications: Injured users may pursue product liability claims for medical expenses, lost wages, and pain and suffering

FDA Notice and Insulet’s Voluntary Medical Device Correction

The FDA posted Insulet’s company announcement in its Recalls, Market Withdrawals & Safety Alerts database in mid-March 2026. This action concerns certain Omnipod 5 pods only—not the entire Omnipod insulin product line.

The FDA’s Center for Devices and Radiological Health also issued an “Early Alert,” flagging this as a potentially high-risk insulin pump device issue. The FDA page provides critical safety information, including the affected UDI (UDI-DI 10385083000527) and an Excel spreadsheet listing all recalled pods by lot number.

Key regulatory details:

• Agency: FDA Center for Devices and Radiological Health
• Classification: Voluntary medical device correction
• Resources: Affected lot spreadsheet, UDI information, safety recommendations
• Status: Pending regulatory action monitoring

Understanding Insulin Delivery Devices

Insulin delivery is at the heart of diabetes management, and for many patients, the Omnipod 5 insulin pump has offered a convenient, tubeless solution for maintaining stable blood sugar. However, the recent recall of certain Omnipod 5 pods has brought to light the critical importance of reliable insulin delivery—and the serious risks that can arise when a medical device fails to perform as intended.

The Omnipod 5 insulin pump is designed to deliver insulin continuously, helping to keep blood glucose levels within a safe range. When the system works as intended, insulin is delivered properly through internal tubing directly into the patient’s body. But with the affected pods, a small tear in the internal tubing can cause insulin to leak inside the pod, resulting in under-delivery of insulin. This means the patient may receive less insulin than needed, or in some cases, none at all.

This disruption in insulin delivery can quickly lead to high blood glucose levels—a serious medical condition that requires prompt medical treatment. If high blood sugar persists, it can progress to diabetic ketoacidosis (DKA), a life-threatening condition that demands immediate intervention. DKA is not only a medical emergency but can also result in hospitalization, significant medical expenses, and lost wages for affected customers. In severe cases, the consequences can be long-lasting or even fatal.

The recall of Omnipod 5 pods underscores the importance of rigorous quality control in the manufacturing of medical devices. Insulet Corporation’s voluntary recall and the FDA’s safety alert highlight how even a small manufacturing defect—like a tear in the internal tubing—can have far-reaching effects, leading to serious adverse events and adverse events connected to insulin leak risk. For patients, this means being vigilant about monitoring blood glucose, recognizing the warning signs of DKA, and responding quickly if something seems wrong with their insulin pump.

Medical device recalls like this one also raise important questions about regulatory oversight and the need for strong clinical evidence to ensure the safety and efficacy of devices before and after they reach the market. The Omnipod 5 recall has prompted affected customers to seek replacement pods and guidance from Insulet Product Support, but it has also led many to consider their legal rights. Patients who have suffered serious complications, such as hospitalization for diabetic ketoacidosis DKA, may be entitled to compensation for medical expenses, lost wages, and other damages. A free case review with an experienced attorney can help clarify these options, often on a contingency basis, so there are no upfront legal fees.

Beyond the immediate health risks, the incident has shaken patient confidence and highlighted the need for clear communication and ongoing support for those using complex medical devices like the Omnipod 5 insulin pump. Patients must be informed about potential risks, proper device maintenance, and what to do if they suspect a problem. As real-world outcomes continue to shape the future of diabetes care, the demand for safe, effective, and reliable insulin delivery systems remains stronger than ever.<

Ultimately, the Omnipod 5 recall serves as a reminder that patient safety must always come first. By understanding the risks of insulin leakage and the importance of prompt medical treatment for high blood glucose levels, patients and their families can take proactive steps to protect their health—and seek justice if they have been harmed by a defective medical device.

How the Omnipod 5 Automated Insulin Delivery System Works

The Omnipod 5 is a tubeless, wearable insulin pump that delivers insulin continuously for up to 72 hours. Unlike traditional pumps, it attaches directly to the skin without external tubing connecting to a separate device.

System components:

• Pod: Contains an insulin reservoir, internal tubing, and a soft cannula that infuses insulin subcutaneously directly into the patient’s body.
• Controller/App: A dedicated controller or compatible smartphone app manages basal rate infusions and bolus doses.
• CGM Integration: Works with continuous glucose monitors from Dexcom or Abbott for automated adjustments.

For people with diabetes—particularly Type 1 and insulin-dependent Type 2—this insulin delivery system operates 24/7 to maintain blood sugar control. When internal tubing fails, the patient receives inadequate insulin without immediate warning, making reliability absolutely critical.

What is the Manufacturing Defect in Omnipod 5 Pods?

Insulet identified that certain pods contain a small tear in the internal tubing that transports insulin from the reservoir to the cannula. This manufacturing defect occurs during production at the company’s facilities and affects specific lots rather than all Omnipod 5 pods.

Defect characteristics:

• Location: Internal tubing within the pod
• Cause: Manufacturing process issue creating tears
• Visibility: Not detectable from outside the pod
• Detection: May not trigger a hazard alarm reliably
• Scope: Approximately 1.5% of the annual global Omnipod 5 pod production

Insulin Leaks and Under-Delivery: What Actually Happens

When the internal tubing tears, insulin leaks and pools inside the pod casing rather than traveling through the cannula into the body. The pod may appear to function normally while the patient receives partial or no insulin.

This insulin leak risk is particularly dangerous overnight or during travel when users check blood glucose levels less frequently. Some users reported alarms or notifications, but Insulet warned that the defect may bypass normal hazard alarm systems.

Practical consequences:

• Pod appears functional, but insulin is not fully infused.
• Persistent high blood glucose readings on CGM without clear pod alerts.
• Under-delivery increases the risk of hyperglycemia progressing to DKA.
• Multiple pods from the same box may all be affected.

What Injuries are Linked to Defective Omnipod Pods?

When defective pods deliver inadequate insulin, blood glucose levels rise. Prolonged hyperglycemia can lead to diabetic ketoacidosis DKA a serious medical condition where the body produces dangerous levels of acidic ketones.

DKA is a medical emergency. Without emergency treatment, it can cause vomiting, confusion, coma, or death. Prompt medical treatment typically involves IV fluids, insulin, and electrolytes, often requiring hospitalization.

Reported injuries and symptoms:

• 18 serious adverse events confirmed by Insulet and noted by the FDA
• Multiple hospitalizations documented
• Cases of DKA requiring emergency care
• No deaths reported as of the latest FDA update

Warning signs of DKA:

• Extreme thirst and frequent urination
• Nausea, vomiting, abdominal pain
• Fruity-smelling breath
• Rapid breathing and confusion

Who Is Most at Risk from Omnipod 5 Failures?

Certain groups face elevated danger from undetected insulin delivery failures:

• Type 1 diabetes patients
• Children who may not recognize or communicate symptoms
• Exclusive Omnipod 5 users without backup delivery methods
• Users during illness when insulin needs fluctuate

Overnight use and travel create additional risk when glucose levels can lead to serious complications before detection. Users receiving multiple pods from the same affected lot box face repeated exposure to defective pods.

Which Omnipod 5 Pods Are Affected?

Only specific Omnipod 5 pod lots distributed in the U.S. are part of this correction. The FDA published the affected UDI-DI (10385083000527) and provided a downloadable Excel spreadsheet listing all affected customers’ lot numbers.

Where to find your pod lot number:

• Printed on the pod tray lid
• Located on the flat side of the pod itself
• Displayed on the outer 5-pack carton
• All pods in a single package share the same lot number

Verification resources:

• FDA recall page
• Insulet’s check-pods tool: omnipod.com/check-pods
• Medical device correction page: omnipod.com/mdc-3-26

What Should Current Omnipod 5 Users Do?

If you have affected pods, take these steps immediately:

1. Stop using affected lot pods and follow Insulet’s correction instructions.
2. Contact your healthcare provider to discuss alternative insulin delivery options.
3. Request replacement pods by calling Insulet Product Support at 1-800-641-2049 (24/7) or using live chat.
4. Monitor blood glucose frequently if you suspect any pod issues.
5. Seek emergency care if DKA symptoms appear.

Insulet provides free replacement pods for affected customers.

Can I File an Omnipod Lawsuit?

Injured Omnipod 5 users may pursue Omnipod lawsuits based on several legal theories: 

• Manufacturing defect: The pod deviated from specifications during production. 
• Failure to warn: Inadequate notification about risks or alarm limitations. 
• Negligent quality control: Insufficient oversight allowed defective pods to reach patients. 

Evidence to preserve:

• Pod packaging showing the pod lot number. 
• Photos of the pod and any visible fluid leak inside the pod. 
• App logs and CGM screenshots showing unexplained highs. 
• Recall notices received. 
• Medical records from emergency visits or hospitalizations. 
• Insulin prescriptions and pharmacy records. 

Potential damages include:

• Hospital bills and ongoing medical expenses 
• Lost wages and diminished earning capacity 
• Pain and suffering 
• Punitive damages (in severe cases with strong clinical evidence of corporate misconduct) 

Do I Qualify to File an Omnipod Lawsuit?

You may qualify to file an Ominipod Lawsuit. People who qualify include: 

• Omnipod 5 users who experienced DKA, hospitalization, or other serious medical emergencies after using affected lot pods. 
• Parents or guardians of injured minor users. 
• Users who have not received formal recall letters but have documented injuries from defective pods. 
• Families pursuing wrongful death claims if a fatality is linked to a defective pod. 

How Much Time Do I Have to File an Omnipod Lawsuit?

Every state sets deadlines for filing product liability claims—typically one to four years from injury or discovery. Delays make obtaining medical records, device data, and physical evidence more difficult. 

Important: Only a licensed attorney in your state can advise on applicable deadlines. Contact a lawyer promptly after any Omnipod-related injury. 

What to Do If You Were Injured by an Omnipod 5 Pod

Follow these steps if you experienced complications from a suspected defective pod:

1. Get immediate medical care for any DKA symptoms or serious medical conditions.
2. Secure the pod and packaging—do not discard before photographing.
3. Document everything: blood glucose readings, symptoms, timeline.
4. Request complete medical records from hospitals and providers.
5. Report to Insulet and arrange replacement pods.
6. File an FDA MedWatch report online or by phone to document the adverse event.
7. Consult with an attorney experienced in medical device recalls.

Contact an Omnipod Lawsuit Attorney for a Free Case Evaluation

The Buckfire Law Firm handles Omnipod lawsuits nationwide and will review your medical history, device records, and recall information to determine if you have a viable claim. We provide a free, no-obligation case review. If you qualify for a claim, we will file your lawsuit with no upfront legal fees or costs, and we will only receive a fee if you win a settlement! 

Legally reviewed by:

Lawrence J. Buckfire, J.D., Lead Trial Attorney at Buckfire Law
Lawrence J. Buckfire, J.D. has over 30 years of experience specializing in personal injury and wrongful death cases. He earned his undergraduate degree from the University of Michigan and attended Wayne State University School of Law. Lawrence has been named a Super Lawyer, U.S. News Best Lawyer, and in The National Trial Lawyers-Top 100 Trial Lawyers.
Date of Review: Mar., 2026